Cargando…
Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality worldwide. Various imaging modalities provide important information about HCC for its clinical management. Since positron-emission tomography (PET) or PET-computed tomography was introduced to the oncologic setting, it h...
Autores principales: | Lu, Ren-Cai, She, Bo, Gao, Wen-Tao, Ji, Yun-Hai, Xu, Dong-Dong, Wang, Quan-Shi, Wang, Shao-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718031/ https://www.ncbi.nlm.nih.gov/pubmed/31528094 http://dx.doi.org/10.3748/wjg.v25.i32.4682 |
Ejemplares similares
-
Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumors
por: Grey, Neil, et al.
Publicado: (2022) -
Deep learning in hepatocellular carcinoma: Current status and future perspectives
por: Ahn, Joseph C, et al.
Publicado: (2021) -
Immunotherapy for hepatocellular carcinoma: Current status and future perspectives
por: Mandlik, Deepa S, et al.
Publicado: (2023) -
Application of artificial intelligence in preoperative imaging of hepatocellular carcinoma: Current status and future perspectives
por: Feng, Bing, et al.
Publicado: (2021) -
Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives
por: Kang, Tae Wook, et al.
Publicado: (2018)